Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CDK2 | P24941 | 6/20 | 0.50 |
| ▸ | GSK3B | P49841 | 7/20 | 0.48 |
| ▸ | CCNE1 | P24864 | 4/20 | 0.46 |
| ▸ | NPC1 | O15118 | 5/20 | 0.45 |
| ▸ | RAB9A | P51151 | 5/20 | 0.45 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.45 |
| ▸ | MEN1 | O00255 | 2/20 | 0.45 |
| ▸ | GAA | P10253 | 3/20 | 0.43 |
| ▸ | KDM4E | B2RXH2 | 3/20 | 0.43 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.43 |
| ▸ | HSD17B10 | Q99714 | 2/20 | 0.43 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.43 |
| ▸ | LMNA | P02545 | 1/20 | 0.41 |
| ▸ | HPGD | P15428 | 1/20 | 0.41 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.41 |
| ▸ | HTT | P42858 | 1/20 | 0.41 |
| ▸ | GFER | P55789 | 1/20 | 0.41 |
| ▸ | POLB | P06746 | 1/20 | 0.40 |
| ▸ | AHR | P35869 | 1/20 | 0.40 |
| ▸ | MAPT | P10636 | 1/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL11930875 | 0.90 | CDK2 (0.64) | CDK2GSK3BCCNE1 | |
| SCHEMBL13304616 | 0.90 | CDK2 (0.49) | CDK2GSK3BCCNE1NPC1RAB9A | |
| SCHEMBL13304911 | 0.80 | CDK2 (0.51) | CDK2GSK3BCCNE1NPC1RAB9A | |
| SCHEMBL5460455 | 0.78 | CDK2 (0.58) | CDK2GSK3BCCNE1NPC1RAB9A | |
| SCHEMBL13305141 | 0.78 | CDK2 (0.55) | CDK2GSK3BCCNE1NPC1RAB9A | |
| SCHEMBL13304893 | 0.77 | GSK3B (0.59) | CDK2GSK3BCCNE1NPC1RAB9A | |
| SCHEMBL12953190 | 0.77 | GSK3B (0.77) | CDK2GSK3BCCNE1 | |
| SCHEMBL13304601 | 0.76 | GSK3B (0.53) | CDK2GSK3BCCNE1NPC1RAB9A | |
| SCHEMBL13304829 | 0.76 | GSK3B (0.51) | CDK2GSK3BCCNE1NPC1RAB9A | |
| SCHEMBL12953588 | 0.74 | NPC1 (0.48) | CDK2GSK3BCCNE1NPC1RAB9A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1537116-B1 | PYRAZOLOPYRIMIDINES SUITABLE FOR THE TREATMENT OF CANCER DISEASES | SCHERING CORP (US) | 2010-06-02 | — | — | EP | disclosed |